Literature DB >> 33708890

Habitual consumption of alcohol with meals and lung cancer: a Mendelian randomization study.

Chongxiang Chen1,2, Qiaozhen Hu1, Jiaojiao Wang3, Tianmeng Wen4, Chaoyang Zhu5, Weiyan Tan5, Xuelin Chen5, Qingyu Zhao1, Wei Wang6, Huijiao Cao1, Huan Li1.   

Abstract

BACKGROUND: The objective of this study was to determine the causal relationship between habitual alcohol consumption with meals and lung cancer.
METHODS: Public genetic summary data from two large consortia [the Neale Lab and the International Lung Cancer Consortium (ILCCO)] were used for analysis. As the instrumental variables of habitual alcohol consumption with meals, data on genetic variants were retrieved from Neale Lab. Additionally, genetic data from other consortia [Global Lipid Genetics Consortium (GLGC), Tobacco, Alcohol and Genetics (TAG), Genetic Investigation of Anthropocentric Traits (GIANT)] were utilized to determine whether alcohol could causally alter some general risk factors for lung cancer. The primary outcome was the risk of lung cancer (11,348 cases and 15,861 controls in the ILCCO). The R package TwoSampleMR was used for analysis.
RESULTS: Based on the inverse variance weighted method, the results of the two-sample Mendelian randomization (MR) analyses indicated that commonly consuming alcohol with meals was a protective factor, reducing lung cancer risk [odds ratio (OR) 0.175, 95% confidence interval (CI): 0.045-0.682, P=0.012]. The heterogeneity analysis revealed that the causal relationship analyses of different types of lung cancer all had low heterogeneity (P>0.05). The horizontal pleiotropic study showed that major bias was unlikely. The MR assumptions did not seem to be violated. The causal relationship analyses between habitual alcohol consumption with meals and some risk factors for cancers showed that this alcohol consumption habit was a beneficial factor for reducing body mass index (BMI) and the number of cigarettes smoked per day.
CONCLUSIONS: Habitual appropriate alcohol consumption with meals is a protective factor for the development of lung cancer. 2021 Annals of Translational Medicine. All rights reserved.

Entities:  

Keywords:  Mendelian randomization; alcohol; lung cancer

Year:  2021        PMID: 33708890      PMCID: PMC7940946          DOI: 10.21037/atm-20-3063

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


Introduction

Conventionally, alcohol consumption has been thought to cause many risk factors towards various diseases, such as obesity; however, a study conducted by Arif et al. (1) indicated that an appropriate alcohol consumption habit (fewer than 5 drinks per week) could decrease the incidence of obesity. Furthermore, for various diseases, several studies have shown that appropriate alcohol consumption (light-to-moderate, less than 30 g/d) is beneficial for patients’ health and can not only reduce the risk of type 2 diabetes (2), arterial hypertension (3), and cardiovascular diseases (4) but can also decrease patient mortality (5). It is estimated that lung cancer, as the first leading cause of cancer death in the USA, will result in more than 130 thousand patient deaths in 2020 (6), with a total 5-year survival rate of 19% (6). It is crucial to clarify modifiable risk factors and beneficial factors to improve the prevention of lung cancer because of the increasing burden (7). Regarding risk factors, smoking has been identified as the most frequent cause of lung cancer (8), and because of tobacco control policies, lung cancer mortality has significantly decreased (6,9,10). In addition, regarding beneficial factors, the study by Zhou et al. (11) showed that education was one of the protective factors for lung cancer, which was proposed by Mendelian randomization (MR). Worldwide interest in MR has greatly increased over the last 10 years; this method uses genome-wide association study (GWAS) data to demonstrate the exact causal relationship between A and B (using instrumental variable analysis with genetic instruments), which can avoid the influences of other exposure factors on the outcomes (12). Previously, several observational studies have shown that appropriate alcohol consumption (amount per day and frequency per week) could prevent lung cancer (13,14). Among these studies, the study by Brenner et al. (13) demonstrated that alcohol intake of less than 20 g/d was a beneficial factor for the prevention of lung cancer. Moreover, Li et al. (14) indicated that occasionally consuming alcohol throughout the week was a favorable factor for the survival of Chinese men with lung cancer. Therefore, we conducted an MR study to confirm the causal relationship between the habitual consumption of alcohol with meals and lung cancer. We present the following article in accordance with the STROBE reporting checklist (available at http://dx.doi.org/10.21037/atm-20-3063).

Methods

Genetic variants associated with lung cancer

The exposure factor data (habitual alcohol consumption with meals) in this study were based on the Neale Lab. The outcome data (incidence of lung cancer, lung adenocarcinoma, and lung squamous cell cancer) were retrieved from the International Lung Cancer Consortium (ILCCO) (15), and the data for small cell lung cancer were obtained from the UK BioBank. In terms of other risk factors, the data of triglycerides and total cholesterol were obtained from the Global Lipid Genetics Consortium (GLGC) (16); the data of smoking habits (including cigarettes smoked per day, former vs. current smoker, age of smoking initiation, and ever vs. never smoker) were obtained from the Tobacco, Alcohol and Genetics (TAG) consortium (17); and the data of obesity class 1–3, waist circumference (adjusted by body mass index, BMI), hip circumference (adjusted by BMI), and waist-to-hip ratio (adjusted by BMI) were retrieved from the Genetic Investigation of Anthropocentric Traits (GIANT) (18,19). ().
Table 1

Details of studies included in Mendelian randomization analyses

VariableConsortiumPMIDPopulationGender
Lung cancerILCCO2488034211,348European
Habitual consumption of alcohol with mealsNeale LabUK BioBank
Obesity 1–3 (waist circumference, hip circumference, waist-to-hip ratio)GIANT23563607, 25673412;European (for obesity 1–3); mixed (waist circumference, hip circumference, waist-to-hip ratio)Mixed
Triglycerides, total cholesterolGLGC24097068MixedMixed
Cigarettes smokingTAG20418890EuropeanMixed

ILCCO, International Lung Cancer Consortium; TAG, Tobacco, Alcohol and Genetics; GLGC, Global Lipids Genetics Consortium; GIANT, Genetic Investigation of Anthropocentric Traits.

ILCCO, International Lung Cancer Consortium; TAG, Tobacco, Alcohol and Genetics; GLGC, Global Lipids Genetics Consortium; GIANT, Genetic Investigation of Anthropocentric Traits.

Statistical analyses

To determine MR estimates of habitual alcohol consumption with meals for lung cancer, we used several MR approaches. In our study, habitual consumption of alcohol meant appropriate alcohol consumption habit (light-to-moderate, less than 30 g/d). We conducted a random effect inverse variance weighted (IVW) meta-analysis of the Wald ratio for individual single nucleotide polymorphisms (SNPs). Other statistical tests (the weighted median and MR-Egger regression methods) were used to estimate the effects. The results are presented as odds ratios (ORs) and 95% confidence intervals (CIs). Three assumptions were the basis of the MR method: (I) the instrumental variables are strongly associated with the habitual consumption of alcohol with meals; (II) the instrumental variables influence lung cancer only through their effect on habitual alcohol consumption with meals; and (III) the instrumental variables are independent of any confounder (20). We assessed the directional pleiotropy based on the intercept obtained from the MR-Egger analysis (21). The common risk factors for lung cancer were identified in previous studies (22,23). Analyses were performed by using the package TwoSampleMR (version 0.3.4) in R (version 3.4.2). The study was conducted in accordance with the Declaration of Helsinki (as revised in 2013).

Results

Causal relationships between appropriate alcohol consumption and lung cancer

The IVW analysis results indicated that habitual appropriate alcohol consumption with meals was a protective factor for lung cancer (OR 0.175, 95% CI: 0.045–0.682, P=0.012) and lung squamous cell cancer (OR 0.075, 95% CI: 0.013–0.429, P=0.004). However, the two-sample MR results of habitual appropriate alcohol consumption with meals and lung adenocarcinoma (OR 1.000, 95% CI: 0.999–1.001, P=0.900), as well as small cell lung cancer (OR 0.247, 95% CI: 0.052–1.169, P=0.078), did not show causal relationships (, ).
Table 2

Results from two sample MR

CancerMethodNumbers of SNPsP valueOR95% CI
Lung cancerMR-Egger140.3750.0022.01E−09 to 1,355.308
Weighted median140.034*0.2010.046–0.885
Inverse variance weighted140.012*0.1750.045–0.682
Small cell lung cancerMR-Egger140.7770.9980.985–1.012
Weighted median140.7961.0000.998–1.002
Inverse variance weighted140.9001.0000.999–1.001
Lung adenocarcinomaMR-Egger140.8873.1087.18E−07 to 13,449,061.81
Weighted median140.0590.1390.018–1.079
Inverse variance weighted140.0780.2470.052–1.169
Squamous cell lung cancerMR-Egger140.1492.36E−061.64E−13 to 33.966
Weighted median140.016*0.0650.007–0.605
Inverse variance weighted140.004*0.0750.013–0.429

*, P value <0.05. MR, Mendelian randomization; SNPs, single nucleotide polymorphisms; OR, odds ratio; CI, confidential index.

Figure 1

Forest plot of the causal effects of alcohol usually taken with meals-associated single nucleotide polymorphisms on lung cancer. MR, Mendelian randomization.

Figure 2

Forest plot of the causal effects of alcohol usually taken with meals-associated single nucleotide polymorphisms on lung squamous cell cancer. MR, Mendelian randomization.

Figure 3

Forest plot of the causal effects of alcohol usually taken with meals-associated single nucleotide polymorphisms on lung adenocarcinoma. MR, Mendelian randomization.

Figure 4

Forest plot of the causal effects of alcohol usually taken with meals-associated single nucleotide polymorphisms on small cell lung cancer. MR, Mendelian randomization.

Figure 5

Scatter plots of genetic associations with alcohol usually taken with meals against the genetic associations with lung cancer. MR, Mendelian randomization; SNP, single nucleotide polymorphism.

*, P value <0.05. MR, Mendelian randomization; SNPs, single nucleotide polymorphisms; OR, odds ratio; CI, confidential index. Forest plot of the causal effects of alcohol usually taken with meals-associated single nucleotide polymorphisms on lung cancer. MR, Mendelian randomization. Forest plot of the causal effects of alcohol usually taken with meals-associated single nucleotide polymorphisms on lung squamous cell cancer. MR, Mendelian randomization. Forest plot of the causal effects of alcohol usually taken with meals-associated single nucleotide polymorphisms on lung adenocarcinoma. MR, Mendelian randomization. Forest plot of the causal effects of alcohol usually taken with meals-associated single nucleotide polymorphisms on small cell lung cancer. MR, Mendelian randomization. Scatter plots of genetic associations with alcohol usually taken with meals against the genetic associations with lung cancer. MR, Mendelian randomization; SNP, single nucleotide polymorphism. The heterogeneity study showed that the heterogeneity in the causal relationship analysis between habitual appropriate alcohol consumption with meals and the incidence of lung cancer was high (P=0.033 for Egger, P=0.039 for IVW); however, the heterogeneities in different types of lung cancer were low (P>0.05 for MR-Egger, and IVW) (). The horizontal pleiotropy study showed that habitual appropriate alcohol consumption with meals did not have multiple effects on other factors of lung cancer (P>0.05) (). The direction of the causal relationship of all MR analyses showed forward causal relationships (P<0.05) ().
Table 3

Heterogeneity tests

CancerMethodQQ_dfP value
Lung cancerMR-Egger22.379120.033*
Inverse variance weighted23.229130.039*
Small cell lung cancerMR-Egger10.322120.588
Inverse variance weighted10.414130.660
Lung adenocarcinomaMR-Egger12.042120.442
Inverse variance weighted12.148130.516
Squamous cell lung cancerMR-Egger14.548120.267
Inverse variance weighted16.411130.228

*, P value <0.05. MR, Mendelian randomization.

Table 4

Test for directional horizontal pleiotropy

CancerEgger_interceptSEP value
Lung cancer0.0470.0700.512
Small cell lung cancer2.10E−056.91E−050.766
Lung adenocarcinoma−0.0250.0780.750
Squamous cell lung cancer0.1050.0840.239

*, P value <0.05. SE, standard error.

Table 5

Test that the exposure is upstream of the outcome

CancerSnp_r2. exposureSnp_r2. outcomeCorrect_causal_directionSteiger_P value
Lung cancer0.0030.001True0.007*
Small cell lung cancer0.0032.31E−05True<0.001*
Lung adenocarcinoma0.0030.001True0.001*
Squamous cell lung cancer0.0030.001True0.026*

*, P value <0.05. SNPs, single nucleotide polymorphisms.

*, P value <0.05. MR, Mendelian randomization. *, P value <0.05. SE, standard error. *, P value <0.05. SNPs, single nucleotide polymorphisms.

Causal relationship between appropriate alcohol consumption and risk factors

The MR analyses between habitual appropriate alcohol consumption with meals and other risk factors for lung cancers showed that the former was a protective factor associated with reduce BMI (OR 0.701, 95% CI: 0.577–0.852, P<0.001) and fewer cigarettes smoked per day (OR 0.002, 95% CI: 3.500E−06 to 0.901, P=0.046). However, other risk factors, including age of smoking initiation (OR 1.140, 95% CI: 0.961–1.354, P=0.133), former vs. current smoker (OR 1.778, 95% CI: 0.532–5.949, P=0.350), total cholesterol (OR 0.707, 95% CI: 0.420–1.189, P=0.192), and triglycerides (OR 0.762, 95% CI: 0.542–1.072, P=0.119), did not show significant causal relationships with habitual appropriate alcohol consumption with meals ().
Table 6

Two sample MR of alcohol consumption and risk factors

Risk factorsNumbers of SNPsP value   OR95% CI
Age of smoking initiation80.1331.1400.961–1.354
BMI14<0.001*0.7010.577–0.852
Total cholesterol80.1920.7070.420–1.189
Triglycerides80.1190.7620.542–1.072
Cigarettes smoked per day80.046*0.0023.50E−06 to 0.901
Former vs. current smoker80.3501.7780.532–5.949

*, P value <0.05. MR, Mendelian randomization; SNPs, single nucleotide polymorphisms; OR, odds ratio; CI, confidential index; BMI, body mass index.

*, P value <0.05. MR, Mendelian randomization; SNPs, single nucleotide polymorphisms; OR, odds ratio; CI, confidential index; BMI, body mass index.

Discussion

The results of our MR study verified the causal relationship between habitual appropriate alcohol consumption with meals and lung cancer. Several studies have supported the idea that light-to-moderate alcohol consumption could not only decrease the incidence of lung cancer (13,24), but could also benefit lung cancer patients’ prognosis. Additionally, light-to-moderate alcohol consumption showed benefits in the studies of many different diseases, including type 2 diabetes (2), arterial hypertension (3), and cardiovascular diseases (4). In this case, we are inclined to conclude that appropriate alcohol consumption is important for health (13,25). The MR analyses between habitual alcohol consumption with meals and some risk factors for lung cancer demonstrated that this causal relationship probably resulted from the phenomenon that people with this habit care more about their health by avoiding some risk factors, such as smoking (fewer cigarettes smoked per day) and so on. On the one hand, the deduced effect above seems reasonable when patients are smokers. On the other hand, for non-smoking lung cancer patients, the study conducted by Fehringer et al. (26) indicated that light-to-moderate alcohol consumers (less than 20 g per day) had lower lung cancer risk than non-drinkers. Furthermore, Garcia Lavandeira et al. (27) suggested that the consumption of almost all kinds of alcohol, except spirits, posed no risk to lung cancer patient survival. To explore the mechanism, we hypothesized that flavonoids found in wine may reduce the risk of some cancers. Support for a beneficial role of flavonoids is provided by several studies where higher dietary intake of flavonoids (including flavonols, flavanones and quercetin) was inversely associated with lung cancer risk (28). For these SNPs included in our MR study, rs4130609 reflected single nucleotide variation in SOX5 gene, which reduced expression by alcohol exposure (29). Moreover, rs113905912 represented single nucleotide variation in KMT2E gene, and the mutation of this gene was associated with various diseases, such as some intellectual disability disorders (30), leukemia (31), and vasculopathy (32). Besides, rs62247171 meant Single nucleotide variation in FOXP1 gene, which could be also related to multiple sclerosis (33), and ischemic stroke (33). The MR results showed that habitual alcohol consumption with meals had an inverse effect on BMI. The study conducted by Arif et al. (1) also demonstrated that compared with nondrinkers, subjects with moderate alcohol consumption (fewer than 5 drinks per week) had a lower BMI. One interesting MR study (34) indicated that regular light-to-moderate alcohol consumption could increase high-density lipoprotein and reduce total glycerides, total cholesterol, and low-density lipoprotein, and according to previous studies, these lipid indicators were associated with lung cancer (35,36). Randomized controlled trials (RCTs) are widely accepted to verify causality, but they are associated with a high cost. Because of the consistently long latency between the exposures and the occurrence of diseases, it is impractical and impossible to investigate all these causal associations through RCTs. However, in MR, genetic markers are used as variables of exposure instead of the exposure itself to facilitate causal inference (37). This method is rarely affected by confounding, reverse causality, and measurement error (38). Additionally, we can implement MR design by using two-sample MR analysis based on published summary data from large-scale GWASs, which greatly increases the scope and statistical power of MR studies (39,40). Our study is the first MR study about alcohol consumption habits (alcohol habitually consumed with meals) and lung cancer. Participants were grouped based on their randomly allocated genotype, mimicking an RCT. However, limitations still exist in our study. First, all the participants included in our study were of European origin. Thus, whether the results can be generalized to other populations still needs to be studied and verified. Moreover, the summary data we used for two-sample MR did not allow for stratified analyses by covariates of interests, such as age and smoking status.

Conclusions

Habitual alcohol consumption with meals has a causal relationship with lung cancer. Furthermore, more work is needed to elucidate the potential mechanisms that mediate the associations between habitual alcohol consumption with meals and lung cancer. The article’s supplementary files as
  40 in total

1.  'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease?

Authors:  George Davey Smith; Shah Ebrahim
Journal:  Int J Epidemiol       Date:  2003-02       Impact factor: 7.196

Review 2.  Mendelian randomization studies: a review of the approaches used and the quality of reporting.

Authors:  Anna G C Boef; Olaf M Dekkers; Saskia le Cessie
Journal:  Int J Epidemiol       Date:  2015-05-06       Impact factor: 7.196

Review 3.  Alcohol Consumption and the Risk of Type 2 Diabetes: A Systematic Review and Dose-Response Meta-analysis of More Than 1.9 Million Individuals From 38 Observational Studies.

Authors:  Craig Knott; Steven Bell; Annie Britton
Journal:  Diabetes Care       Date:  2015-09       Impact factor: 19.112

4.  Shared genetic variants for polypoidal choroidal vasculopathy and typical neovascular age-related macular degeneration in East Asians.

Authors:  Qiao Fan; Chui Ming Gemmy Cheung; Li Jia Chen; Kenji Yamashiro; Jeeyun Ahn; Augustinus Laude; Ranjana Mathur; Chan Choi Mun; Ian Y Yeo; Tock Han Lim; Yik-Ying Teo; Chiea Chuen Khor; Kyu-Hyung Park; Nagahisa Yoshimura; Chi Pui Pang; Tien Yin Wong; Ching-Yu Cheng
Journal:  J Hum Genet       Date:  2017-08-24       Impact factor: 3.172

5.  Dietary quercetin, quercetin-gene interaction, metabolic gene expression in lung tissue and lung cancer risk.

Authors:  Tram Kim Lam; Melissa Rotunno; Jay H Lubin; Sholom Wacholder; Dario Consonni; Angela C Pesatori; Pier Alberto Bertazzi; Stephen J Chanock; Laurie Burdette; Alisa M Goldstein; Margaret A Tucker; Neil E Caporaso; Amy F Subar; Maria Teresa Landi
Journal:  Carcinogenesis       Date:  2009-12-31       Impact factor: 4.944

6.  Alteration of gene expression by alcohol exposure at early neurulation.

Authors:  Feng C Zhou; Qianqian Zhao; Yunlong Liu; Charles R Goodlett; Tiebing Liang; Jeanette N McClintick; Howard J Edenberg; Lang Li
Journal:  BMC Genomics       Date:  2011-02-21       Impact factor: 3.969

7.  Using published data in Mendelian randomization: a blueprint for efficient identification of causal risk factors.

Authors:  Stephen Burgess; Robert A Scott; Nicholas J Timpson; George Davey Smith; Simon G Thompson
Journal:  Eur J Epidemiol       Date:  2015-03-15       Impact factor: 8.082

8.  Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture.

Authors:  Sonja I Berndt; Stefan Gustafsson; Reedik Mägi; Andrea Ganna; Eleanor Wheeler; Mary F Feitosa; Anne E Justice; Keri L Monda; Damien C Croteau-Chonka; Felix R Day; Tõnu Esko; Tove Fall; Teresa Ferreira; Davide Gentilini; Anne U Jackson; Jian'an Luan; Joshua C Randall; Sailaja Vedantam; Cristen J Willer; Thomas W Winkler; Andrew R Wood; Tsegaselassie Workalemahu; Yi-Juan Hu; Sang Hong Lee; Liming Liang; Dan-Yu Lin; Josine L Min; Benjamin M Neale; Gudmar Thorleifsson; Jian Yang; Eva Albrecht; Najaf Amin; Jennifer L Bragg-Gresham; Gemma Cadby; Martin den Heijer; Niina Eklund; Krista Fischer; Anuj Goel; Jouke-Jan Hottenga; Jennifer E Huffman; Ivonne Jarick; Åsa Johansson; Toby Johnson; Stavroula Kanoni; Marcus E Kleber; Inke R König; Kati Kristiansson; Zoltán Kutalik; Claudia Lamina; Cecile Lecoeur; Guo Li; Massimo Mangino; Wendy L McArdle; Carolina Medina-Gomez; Martina Müller-Nurasyid; Julius S Ngwa; Ilja M Nolte; Lavinia Paternoster; Sonali Pechlivanis; Markus Perola; Marjolein J Peters; Michael Preuss; Lynda M Rose; Jianxin Shi; Dmitry Shungin; Albert Vernon Smith; Rona J Strawbridge; Ida Surakka; Alexander Teumer; Mieke D Trip; Jonathan Tyrer; Jana V Van Vliet-Ostaptchouk; Liesbeth Vandenput; Lindsay L Waite; Jing Hua Zhao; Devin Absher; Folkert W Asselbergs; Mustafa Atalay; Antony P Attwood; Anthony J Balmforth; Hanneke Basart; John Beilby; Lori L Bonnycastle; Paolo Brambilla; Marcel Bruinenberg; Harry Campbell; Daniel I Chasman; Peter S Chines; Francis S Collins; John M Connell; William O Cookson; Ulf de Faire; Femmie de Vegt; Mariano Dei; Maria Dimitriou; Sarah Edkins; Karol Estrada; David M Evans; Martin Farrall; Marco M Ferrario; Jean Ferrières; Lude Franke; Francesca Frau; Pablo V Gejman; Harald Grallert; Henrik Grönberg; Vilmundur Gudnason; Alistair S Hall; Per Hall; Anna-Liisa Hartikainen; Caroline Hayward; Nancy L Heard-Costa; Andrew C Heath; Johannes Hebebrand; Georg Homuth; Frank B Hu; Sarah E Hunt; Elina Hyppönen; Carlos Iribarren; Kevin B Jacobs; John-Olov Jansson; Antti Jula; Mika Kähönen; Sekar Kathiresan; Frank Kee; Kay-Tee Khaw; Mika Kivimäki; Wolfgang Koenig; Aldi T Kraja; Meena Kumari; Kari Kuulasmaa; Johanna Kuusisto; Jaana H Laitinen; Timo A Lakka; Claudia Langenberg; Lenore J Launer; Lars Lind; Jaana Lindström; Jianjun Liu; Antonio Liuzzi; Marja-Liisa Lokki; Mattias Lorentzon; Pamela A Madden; Patrik K Magnusson; Paolo Manunta; Diana Marek; Winfried März; Irene Mateo Leach; Barbara McKnight; Sarah E Medland; Evelin Mihailov; Lili Milani; Grant W Montgomery; Vincent Mooser; Thomas W Mühleisen; Patricia B Munroe; Arthur W Musk; Narisu Narisu; Gerjan Navis; George Nicholson; Ellen A Nohr; Ken K Ong; Ben A Oostra; Colin N A Palmer; Aarno Palotie; John F Peden; Nancy Pedersen; Annette Peters; Ozren Polasek; Anneli Pouta; Peter P Pramstaller; Inga Prokopenko; Carolin Pütter; Aparna Radhakrishnan; Olli Raitakari; Augusto Rendon; Fernando Rivadeneira; Igor Rudan; Timo E Saaristo; Jennifer G Sambrook; Alan R Sanders; Serena Sanna; Jouko Saramies; Sabine Schipf; Stefan Schreiber; Heribert Schunkert; So-Youn Shin; Stefano Signorini; Juha Sinisalo; Boris Skrobek; Nicole Soranzo; Alena Stančáková; Klaus Stark; Jonathan C Stephens; Kathleen Stirrups; Ronald P Stolk; Michael Stumvoll; Amy J Swift; Eirini V Theodoraki; Barbara Thorand; David-Alexandre Tregouet; Elena Tremoli; Melanie M Van der Klauw; Joyce B J van Meurs; Sita H Vermeulen; Jorma Viikari; Jarmo Virtamo; Veronique Vitart; Gérard Waeber; Zhaoming Wang; Elisabeth Widén; Sarah H Wild; Gonneke Willemsen; Bernhard R Winkelmann; Jacqueline C M Witteman; Bruce H R Wolffenbuttel; Andrew Wong; Alan F Wright; M Carola Zillikens; Philippe Amouyel; Bernhard O Boehm; Eric Boerwinkle; Dorret I Boomsma; Mark J Caulfield; Stephen J Chanock; L Adrienne Cupples; Daniele Cusi; George V Dedoussis; Jeanette Erdmann; Johan G Eriksson; Paul W Franks; Philippe Froguel; Christian Gieger; Ulf Gyllensten; Anders Hamsten; Tamara B Harris; Christian Hengstenberg; Andrew A Hicks; Aroon Hingorani; Anke Hinney; Albert Hofman; Kees G Hovingh; Kristian Hveem; Thomas Illig; Marjo-Riitta Jarvelin; Karl-Heinz Jöckel; Sirkka M Keinanen-Kiukaanniemi; Lambertus A Kiemeney; Diana Kuh; Markku Laakso; Terho Lehtimäki; Douglas F Levinson; Nicholas G Martin; Andres Metspalu; Andrew D Morris; Markku S Nieminen; Inger Njølstad; Claes Ohlsson; Albertine J Oldehinkel; Willem H Ouwehand; Lyle J Palmer; Brenda Penninx; Chris Power; Michael A Province; Bruce M Psaty; Lu Qi; Rainer Rauramaa; Paul M Ridker; Samuli Ripatti; Veikko Salomaa; Nilesh J Samani; Harold Snieder; Thorkild I A Sørensen; Timothy D Spector; Kari Stefansson; Anke Tönjes; Jaakko Tuomilehto; André G Uitterlinden; Matti Uusitupa; Pim van der Harst; Peter Vollenweider; Henri Wallaschofski; Nicholas J Wareham; Hugh Watkins; H-Erich Wichmann; James F Wilson; Goncalo R Abecasis; Themistocles L Assimes; Inês Barroso; Michael Boehnke; Ingrid B Borecki; Panos Deloukas; Caroline S Fox; Timothy Frayling; Leif C Groop; Talin Haritunian; Iris M Heid; David Hunter; Robert C Kaplan; Fredrik Karpe; Miriam F Moffatt; Karen L Mohlke; Jeffrey R O'Connell; Yudi Pawitan; Eric E Schadt; David Schlessinger; Valgerdur Steinthorsdottir; David P Strachan; Unnur Thorsteinsdottir; Cornelia M van Duijn; Peter M Visscher; Anna Maria Di Blasio; Joel N Hirschhorn; Cecilia M Lindgren; Andrew P Morris; David Meyre; André Scherag; Mark I McCarthy; Elizabeth K Speliotes; Kari E North; Ruth J F Loos; Erik Ingelsson
Journal:  Nat Genet       Date:  2013-04-07       Impact factor: 38.330

9.  Discovery and refinement of loci associated with lipid levels.

Authors:  Cristen J Willer; Ellen M Schmidt; Sebanti Sengupta; Michael Boehnke; Panos Deloukas; Sekar Kathiresan; Karen L Mohlke; Erik Ingelsson; Gonçalo R Abecasis; Gina M Peloso; Stefan Gustafsson; Stavroula Kanoni; Andrea Ganna; Jin Chen; Martin L Buchkovich; Samia Mora; Jacques S Beckmann; Jennifer L Bragg-Gresham; Hsing-Yi Chang; Ayşe Demirkan; Heleen M Den Hertog; Ron Do; Louise A Donnelly; Georg B Ehret; Tõnu Esko; Mary F Feitosa; Teresa Ferreira; Krista Fischer; Pierre Fontanillas; Ross M Fraser; Daniel F Freitag; Deepti Gurdasani; Kauko Heikkilä; Elina Hyppönen; Aaron Isaacs; Anne U Jackson; Åsa Johansson; Toby Johnson; Marika Kaakinen; Johannes Kettunen; Marcus E Kleber; Xiaohui Li; Jian'an Luan; Leo-Pekka Lyytikäinen; Patrik K E Magnusson; Massimo Mangino; Evelin Mihailov; May E Montasser; Martina Müller-Nurasyid; Ilja M Nolte; Jeffrey R O'Connell; Cameron D Palmer; Markus Perola; Ann-Kristin Petersen; Serena Sanna; Richa Saxena; Susan K Service; Sonia Shah; Dmitry Shungin; Carlo Sidore; Ci Song; Rona J Strawbridge; Ida Surakka; Toshiko Tanaka; Tanya M Teslovich; Gudmar Thorleifsson; Evita G Van den Herik; Benjamin F Voight; Kelly A Volcik; Lindsay L Waite; Andrew Wong; Ying Wu; Weihua Zhang; Devin Absher; Gershim Asiki; Inês Barroso; Latonya F Been; Jennifer L Bolton; Lori L Bonnycastle; Paolo Brambilla; Mary S Burnett; Giancarlo Cesana; Maria Dimitriou; Alex S F Doney; Angela Döring; Paul Elliott; Stephen E Epstein; Gudmundur Ingi Eyjolfsson; Bruna Gigante; Mark O Goodarzi; Harald Grallert; Martha L Gravito; Christopher J Groves; Göran Hallmans; Anna-Liisa Hartikainen; Caroline Hayward; Dena Hernandez; Andrew A Hicks; Hilma Holm; Yi-Jen Hung; Thomas Illig; Michelle R Jones; Pontiano Kaleebu; John J P Kastelein; Kay-Tee Khaw; Eric Kim; Norman Klopp; Pirjo Komulainen; Meena Kumari; Claudia Langenberg; Terho Lehtimäki; Shih-Yi Lin; Jaana Lindström; Ruth J F Loos; François Mach; Wendy L McArdle; Christa Meisinger; Braxton D Mitchell; Gabrielle Müller; Ramaiah Nagaraja; Narisu Narisu; Tuomo V M Nieminen; Rebecca N Nsubuga; Isleifur Olafsson; Ken K Ong; Aarno Palotie; Theodore Papamarkou; Cristina Pomilla; Anneli Pouta; Daniel J Rader; Muredach P Reilly; Paul M Ridker; Fernando Rivadeneira; Igor Rudan; Aimo Ruokonen; Nilesh Samani; Hubert Scharnagl; Janet Seeley; Kaisa Silander; Alena Stančáková; Kathleen Stirrups; Amy J Swift; Laurence Tiret; Andre G Uitterlinden; L Joost van Pelt; Sailaja Vedantam; Nicholas Wainwright; Cisca Wijmenga; Sarah H Wild; Gonneke Willemsen; Tom Wilsgaard; James F Wilson; Elizabeth H Young; Jing Hua Zhao; Linda S Adair; Dominique Arveiler; Themistocles L Assimes; Stefania Bandinelli; Franklyn Bennett; Murielle Bochud; Bernhard O Boehm; Dorret I Boomsma; Ingrid B Borecki; Stefan R Bornstein; Pascal Bovet; Michel Burnier; Harry Campbell; Aravinda Chakravarti; John C Chambers; Yii-Der Ida Chen; Francis S Collins; Richard S Cooper; John Danesh; George Dedoussis; Ulf de Faire; Alan B Feranil; Jean Ferrières; Luigi Ferrucci; Nelson B Freimer; Christian Gieger; Leif C Groop; Vilmundur Gudnason; Ulf Gyllensten; Anders Hamsten; Tamara B Harris; Aroon Hingorani; Joel N Hirschhorn; Albert Hofman; G Kees Hovingh; Chao Agnes Hsiung; Steve E Humphries; Steven C Hunt; Kristian Hveem; Carlos Iribarren; Marjo-Riitta Järvelin; Antti Jula; Mika Kähönen; Jaakko Kaprio; Antero Kesäniemi; Mika Kivimaki; Jaspal S Kooner; Peter J Koudstaal; Ronald M Krauss; Diana Kuh; Johanna Kuusisto; Kirsten O Kyvik; Markku Laakso; Timo A Lakka; Lars Lind; Cecilia M Lindgren; Nicholas G Martin; Winfried März; Mark I McCarthy; Colin A McKenzie; Pierre Meneton; Andres Metspalu; Leena Moilanen; Andrew D Morris; Patricia B Munroe; Inger Njølstad; Nancy L Pedersen; Chris Power; Peter P Pramstaller; Jackie F Price; Bruce M Psaty; Thomas Quertermous; Rainer Rauramaa; Danish Saleheen; Veikko Salomaa; Dharambir K Sanghera; Jouko Saramies; Peter E H Schwarz; Wayne H-H Sheu; Alan R Shuldiner; Agneta Siegbahn; Tim D Spector; Kari Stefansson; David P Strachan; Bamidele O Tayo; Elena Tremoli; Jaakko Tuomilehto; Matti Uusitupa; Cornelia M van Duijn; Peter Vollenweider; Lars Wallentin; Nicholas J Wareham; John B Whitfield; Bruce H R Wolffenbuttel; Jose M Ordovas; Eric Boerwinkle; Colin N A Palmer; Unnur Thorsteinsdottir; Daniel I Chasman; Jerome I Rotter; Paul W Franks; Samuli Ripatti; L Adrienne Cupples; Manjinder S Sandhu; Stephen S Rich
Journal:  Nat Genet       Date:  2013-10-06       Impact factor: 38.330

10.  Causal Role of Alcohol Consumption in an Improved Lipid Profile: The Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Khanh N Vu; Christie M Ballantyne; Ron C Hoogeveen; Vijay Nambi; Kelly A Volcik; Eric Boerwinkle; Alanna C Morrison
Journal:  PLoS One       Date:  2016-02-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.